Cervical dysplasia – Diagnostics – Overview of Information and Clinical Research

Cervical dysplasia is a condition where abnormal cells appear on the surface of the cervix, but these cells are not cancer yet. The good news is that with proper screening and early detection, cervical dysplasia can be identified and managed before it ever has a chance to become something more serious.

Introduction: Who Should Undergo Diagnostics

Regular screening for cervical dysplasia is essential for anyone with a cervix. Most people with this condition experience no symptoms at all, which is why routine testing is so important. The abnormal cells simply grow quietly on the cervical surface without causing pain or discomfort.^[1]

Healthcare providers typically recommend that people begin cervical cancer screening at age 21. Between ages 21 and 29, healthy individuals should have a Pap test (also called a Pap smear) every three years. A Pap test is a simple procedure where a healthcare provider collects a small sample of cells from the cervix to examine under a microscope.^[2]

For individuals aged 30 through 65, doctors may offer a Pap test every three years, or a Pap test combined with human papillomavirus (HPV) testing every five years. More recently, HPV testing alone for people aged 25 and older can also be used for cervical screening. These tests help catch abnormal cells before they can progress to cancer.^[2]

Some people may need more frequent testing depending on their personal risk factors and previous test results. If you’ve had abnormal test results in the past, been diagnosed with cervical dysplasia before, or know you’re HPV-positive, your doctor may want to monitor you more closely.^[2]

While cervical dysplasia usually doesn’t cause symptoms, some individuals may notice irregular vaginal bleeding, spotting after sexual intercourse, abnormal vaginal discharge, or painful sex. If you experience any of these symptoms, it’s important to see your healthcare provider, even if your next scheduled screening isn’t due yet.^[2]

⚠️ Important

Between 250,000 and 1 million people are diagnosed with cervical dysplasia in the United States each year. Most people are 25 to 35 years old, although it can occur at almost any age. Regular screening is your best defense, as cervical cancer is completely preventable when dysplasia is identified early and treated.^[4]

Diagnostic Methods

The Pap Smear: First Line of Detection

The Pap test is the most important screening tool for detecting cervical dysplasia. During a routine gynecological pelvic exam, your healthcare provider will insert a speculum (a device that gently widens the vagina) so they can see your cervix at the top of the vagina. They then use a small swab or brush to gently scrape cells from the surface of your cervix. This procedure is generally not painful, though some people may feel slight pressure or discomfort.^[6]

The collected cells are sent to a laboratory where a specialist called a pathologist examines them under a microscope. This analysis can reveal whether the cells look normal or show signs of abnormal changes. It can take up to three weeks for the laboratory to process the test and send results back to your doctor.^[6]

Pap test results can be categorized as normal, inconclusive, or abnormal. Normal results mean you should continue with routine screening as recommended. Inconclusive results don’t necessarily indicate cervical dysplasia—you might simply have a mild infection in your cervix or vagina. In this case, your doctor may order a repeat Pap test.^[6]

If the Pap test shows abnormal results, the findings will be described in specific terms. On the Pap test report, abnormal changes may be labeled as low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), possibly cancerous (malignant), atypical glandular cells, or atypical squamous cells.^[7]

HPV Testing

An HPV test is often performed alongside or after an abnormal Pap test. This test detects the presence of human papillomavirus, which is the virus responsible for causing cervical dysplasia in almost all cases. There are more than 200 types of HPV, but only certain high-risk types are linked to cervical dysplasia and cancer.^[2]

The HPV test uses the same cell sample collected during a Pap test, so you don’t need a separate procedure. The test can identify whether you have one of the high-risk HPV types, particularly HPV type 16 and type 18, which are most commonly associated with cervical dysplasia. HPV type 16 alone is responsible for 50% of cervical cancer cases.^[8]

An HPV DNA test may be done as a screening test for individuals aged 30 or older, or for people of any age who have a slightly abnormal Pap test result. The test helps healthcare providers determine whether further diagnostic procedures are needed.^[7]

Colposcopy: A Closer Look at the Cervix

If your Pap test reveals abnormal cells, your healthcare provider may recommend a colposcopy. This is not a routine screening test but rather a diagnostic procedure used to examine your cervix more closely. A colposcope is a special lighted instrument with magnification that allows your doctor to see the cervix, vagina, and vulva in greater detail.^[1]

During a colposcopy, your doctor will apply a solution to your cervix—typically acetic acid (similar to vinegar) followed by Lugol’s iodine solution. The acetic acid test should be scored after one minute, and the Lugol’s iodine test helps identify areas of abnormal tissue that may need closer examination. These solutions make abnormal areas more visible by causing them to appear white or not absorbing the iodine stain like normal tissue does.^[13]

The colposcopy procedure is usually performed in your doctor’s office and takes about 10 to 20 minutes. While it may feel uncomfortable, it typically isn’t painful. Your doctor uses the colposcope to identify any abnormal areas on your cervix that may require a tissue sample for further testing.^[1]

Cervical Biopsy: Confirming the Diagnosis

If your doctor sees abnormal areas during the colposcopy, they will perform a biopsy. A biopsy involves removing small tissue samples from the cervix that a pathologist will examine in a laboratory. The biopsies are very small, and most people feel only a small cramp during the procedure.^[7]

The biopsy results provide a definitive diagnosis by showing exactly how abnormal the cells are. When dysplasia is seen on a biopsy of the cervix, it’s called cervical intraepithelial neoplasia (CIN). The term “intraepithelial” means the abnormal cells are on the surface layer of your cervix and haven’t grown deeper into the tissue. “Neoplasia” simply means abnormal cell growth.^[1]

Healthcare providers classify cervical dysplasia into three categories based on how much of the cervical tissue looks abnormal under a microscope. CIN 1 means abnormal cells affect about one-third of the thickness of the surface layer. CIN 2 indicates abnormal cells affect about one-third to two-thirds of the tissue. CIN 3 shows that abnormal cells affect more than two-thirds of the epithelium.^[1]

Understanding the grade of dysplasia is crucial because it helps determine what happens next. CIN 1 is considered mild dysplasia and rarely becomes cancer—it often goes away on its own without treatment. CIN 2 and CIN 3 are more serious and are more likely to require treatment to prevent cancer.^[1]

⚠️ Important

Healthcare providers may use intravenous or intracervical lidocaine (a numbing medication) for pain reduction during colposcopically-directed cervical biopsies. After cervical biopsies, a solution called Monsel’s solution might be used to control any bleeding. These measures help make the diagnostic process more comfortable for patients.^[13]

Diagnostics for Clinical Trial Qualification

Clinical trials studying treatments for cervical dysplasia use specific diagnostic criteria to determine which patients can participate. The standard diagnostic tests described above—Pap smears, HPV testing, colposcopy, and cervical biopsy—form the foundation for qualifying patients for research studies.^[13]

For enrollment in clinical trials, researchers typically require confirmation of cervical dysplasia through a cervical biopsy showing CIN. The exact grade of CIN needed varies depending on the trial. Some studies may focus on patients with low-grade dysplasia (CIN 1), while others may specifically recruit individuals with moderate to severe dysplasia (CIN 2 or CIN 3).^[13]

HPV testing is often required as part of clinical trial qualification. Since HPV infection causes almost all cases of cervical dysplasia, knowing a patient’s HPV status and which specific type of HPV is present helps researchers understand how the condition might respond to experimental treatments. Trials may require patients to test positive for specific high-risk HPV types.^[4]

Before enrolling in a clinical trial, patients typically undergo a complete diagnostic workup including a thorough medical history, physical examination, Pap test, HPV testing, colposcopy, and biopsy. These baseline assessments establish the severity of the dysplasia and ensure that patients meet all inclusion criteria for the study. Regular follow-up testing during the trial helps researchers monitor whether the experimental treatment is working.^[13]

Some clinical trials may also use additional diagnostic techniques beyond the standard tests. For example, researchers might collect extra tissue samples for genetic testing or use specialized imaging methods to better characterize the abnormal cells. These additional tests help scientists learn more about cervical dysplasia and how different treatments affect the condition.^[13]

Prognosis and Survival Rate

Prognosis

The outlook for people diagnosed with cervical dysplasia is generally very positive, especially when the condition is detected early and monitored or treated appropriately. Most individuals with cervical dysplasia do not develop cervical cancer. Receiving a cervical dysplasia diagnosis means that cancer might develop if left untreated—not that it will definitely occur.^[1]

The prognosis depends largely on the grade of dysplasia. Mild dysplasia (CIN 1 or LSIL) frequently resolves on its own without any treatment. Many people’s immune systems successfully clear the HPV infection that caused the abnormal cell changes, allowing the cervical tissue to return to normal. For this reason, doctors often recommend watchful waiting for mild dysplasia, with repeat testing every six to twelve months to monitor the condition.^[7]

Moderate to severe dysplasia (CIN 2 and CIN 3) is more likely to persist or progress if not treated. However, even these higher grades of dysplasia can be successfully managed with various treatment options. Early diagnosis and prompt treatment cure most cases of cervical dysplasia. About 100,000 women receive treatment for cervical dysplasia each year in the United States.^[1]

Several factors can affect the prognosis and likelihood of dysplasia resolving on its own or requiring treatment. The specific strain of HPV involved plays a role, with certain high-risk types like HPV-16 and HPV-18 being more likely to cause persistent dysplasia. How long you’ve had the untreated infection also matters. Additionally, having a weakened immune system makes it harder for your body to fight the HPV infection, which can affect outcomes.^[1]

After treatment, cervical dysplasia can sometimes return. This is why ongoing follow-up care is essential. If you’ve had dysplasia, you will need repeat examinations every 12 months or as suggested by your healthcare provider. Regular monitoring ensures that any recurrence is caught early and can be addressed promptly.^[7]

With regular screening and follow-up for abnormal results, cervical cancer is completely preventable. This is because cervical dysplasia can be identified early and is easily treatable with low-risk procedures. The slow progression from dysplasia to cancer—which usually occurs over several years—provides ample opportunity for intervention.^[2]

Survival Rate

While specific survival rate statistics for cervical dysplasia itself are not typically reported (since dysplasia is a precancerous condition rather than cancer), understanding the relationship between dysplasia and cervical cancer provides important context. Without detection and treatment, severe cervical dysplasia can change into cervical cancer over time. However, this progression usually happens slowly, over a period of several years.^[7]

The introduction of routine Pap testing has dramatically reduced cervical cancer deaths. The Pap smear is responsible for decreasing both the incidence of and mortality rates from cervical cancer. Each year in the United States, about 11,500 new cases of cervical cancer are diagnosed and about 4,000 people die of this cancer. Most people who are diagnosed with cervical cancer have not been screened recently, highlighting the critical importance of regular diagnostic testing.^[18]

The high success rate of screening and early treatment means that most people diagnosed with cervical dysplasia never progress to cancer. This underscores why maintaining regular screening appointments and following through with recommended diagnostic tests and treatments is so crucial for long-term health outcomes.^[4]

#1 Clinical Trials Search in Europe